Track topics on Twitter Track topics that are important to you
Novo Nordisk A/S has earned a consensus rating of "Hold" from the eleven brokerages that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company.
Original Article: Novo Nordisk A/S (NVO) Receives Average Rating of "Hold" from AnalystsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...